Highly potent actives (HPAPIs)
News
SAFC opens US$30m HPAPI facility – 6-Apr-2010
The expansion significantly increases SAFC's capacity to produce commercial scale HPAPIs
Catalent adds potent drug capabilities at Schorndorf – 2-Feb-2010
Catalent Pharma Solutions, a global provider of outsourced dose form manufacturing and packaging to the pharmaceutical industry, has expanded its capabilities at its Schorndorf, Germany site to include a new potent products area.
Novasep gains SafeBridge certification at Le Mans HPAPI plant – 18-Sep-2009
Novasep's site in Le Mans, France, which manufactures highly potent active pharmaceutical Ingredients (HPAPIs), has received potent compound safety certification from SafeBridge Consultants.
Almac Sciences' cytotoxics plant gains SafeBridge certification – 22-Feb-2007
Almac Sciences, a division of the Almac Group, has been granted SafeBridge certification in the safe handling of potent pharmaceutical compounds for its cytotoxic and potent compound manufacturing operations.
Articles
Contained but not constrained – 20-May-2010
Highly potent drugs require specialised manufacturing facilities to ensure they do not escape into the environment. SAFC’s Trevor Calkins describes how the company designed its multipurpose manufacturing plants to meet the complex containment requirements
Handling potent drug materials – 16-Apr-2010
Drug manufacturer Hovione has opened a new spray drying facility in Loures, Portugal, for potent active ingredients. Marco Marques, head of production, describes the safety protocols
Jobs & People
Cerbios-Pharma gains new director of commercial business development – 27-Apr-2010
Will help firm to grow and strengthen HPAPI services